Letermovir Approved for Cytomegalovirus Prophylaxis in Kidney Transplant Recipients
Letermovir appears to be better tolerated than the current standard of care, valganciclovir, a prodrug of ganciclovir, which frequently causes myelosuppression.
Letermovir appears to be better tolerated than the current standard of care, valganciclovir, a prodrug of ganciclovir, which frequently causes myelosuppression.
Severe renal dysfunction and short-term dialysis are common before heart-alone transplantation, a study found.
Current screening guidelines may not capture all cases of hyperaldosteronism among patients with ESKD.
Hospitalization of living kidney donors may be “a sentinel event” for adverse outcomes.
An online public opinion survey of US adults uncovers widespread concern about the health effects of donating a kidney and associated medical expenses.
Removing the race coefficient from the KDPI may increase use of Black deceased donor kidneys, according to investigators.
Findings from a prospective, randomized trial indicate that wound healing problems observed in early studies of high exposure to mTOR inhibitors can be prevented by using a dual regimen of everolimus and tacrolimus in low doses.
Patients receiving their first kidney transplant are at 18% higher risk for newly diagnosed atrial fibrillation if they were on hemodialysis rather than peritoneal dialysis prior to transplantation, a study found.
Venous thromboembolism occurred in the graft in 15.4% of patients.
Vitamin K deficiency is common among kidney transplant recipients.